<<

§ 522.2690 21 CFR Ch. I (4–1–05 Edition)

effectiveness have not been established 524.660b Dimethyl sulfoxide gel. in veal calves. A withdrawal period has 524.770 Doramectin. not been established for this product in 524.802 Enrofloxacin, silver sulfadiazine preruminating calves. Do not use in emulsion. calves to be processed for veal. 524.814 Eprinomectin. 524.900 Famphur. [59 FR 19639, Apr. 25, 1994; 60 FR 26360, May 524.920 Fenthion. 17, 1995, as amended at 62 FR 61625, Nov. 19, 524.960 Flumethasone, sulfate, 1997; 64 FR 46840, Aug. 27, 1999; 67 FR 6867, and sulfate ophthalmic so- Feb. 14, 2002; 70 FR 6764, Feb. 9, 2005] lutions. 524.981 acetonide ophthalmic § 522.2690 Zinc gluconate. and topical dosage forms. (a) Specifications. Each milliliter of 524.981a cream. solution contains 13.1 milligrams zinc 524.981b Fluocinolone acetonide solution. 524.981c Fluocinolone acetonide, neomycin as zinc gluconate neutralized to pH 7.0 sulfate cream. with L-arginine. 524.981d Fluocinolone acetonide, dimethyl (b) Sponsor. See No. 067647 in sulfoxide solution. § 510.600(c) of this chapter. 524.981e Fluocinolone acetonide, dimethyl (c) Conditions of use in dogs—(1) sulfoxide otic solution. Amount. The volume injected into each 524.1005 aerosol powder. testicle is based on testicular width as 524.1044 sulfate ophthalmic and determined by measuring each testicle topical dosage forms. at its widest point using a metric scale 524.1044a Gentamicin ophthalmic solution. (millimeter) caliper. 524.1044b Gentamicin sulfate, (2) Indications for use. Intratesticular valerate otic solution. 524.1044c Gentamicin sulfate ophthalmic injection for chemical sterilization of ointment. 3- to 10-month-old male dogs. 524.1044d Gentamicin sulfate, (3) Limitations. Federal law restricts ointment. this drug to use by or on the order of a 524.1044e Gentamicin sulfate spray. licensed veterinarian. 524.1044f Gentamicin sulfate, betamethasone valerate topical spray. [68 FR 26995, May 19, 2003] 524.1044g Gentamicin sulfate, betamethasone valerate, PART 524—OPHTHALMIC AND TOP- ointment. ICAL DOSAGE FORM NEW ANI- 524.1044h Gentamicin sulfate, MAL DRUGS furoate, clotrimazole otic suspension. 524.1140 Imidacloprid and ivermectin. 524.1193 Ivermectin pour-on. Sec. 524.1195 Ivermectin otic suspension. 524.86 Amitraz liquid. 524.1200 Kanamycin ophthalmic and topical 524.154 Bacitracin or bacitracin zinc-neomy- dosage forms. cin sulfate-polymyxin B sulfate oph- 524.1200a Kanamycin ophthalmic ointment. thalmic ointment. 524.1200b Kanamycin ophthalmic aqueous 524.155 Bacitracin zinc-polymyxin B sulfate- solution. neomycin sulfate- or hy- drocortisone acetate ophthalmic oint- 524.1204 Kanamycin sulfate, calcium ment. amphomycin, and hydrocortisone ace- 524.390 ophthalmic and tate. topical dosage forms. 524.1240 Levamisole. 524.390a Chloramphenicol ophthalmic oint- 524.1376 2-Mercaptobenzothiazole solution. ment. 524.1443 Miconazole nitrate cream; 524.390b Chloramphenicol ophthalmic solu- miconazole nitrate lotion; miconazole ni- tion. trate spray. 524.390d Chloramphenicol- oph- 524.1446 Milbemycin oxime solution. thalmic ointment. 524.1451 Moxidectin. 524.402 ointment. 524.1465 Mupirocin ointment. 524.450 Clotrimazole cream. 524.1484 Neomycin sulfate ophthalmic and 524.463 Copper naphthenate solution. topical dosage forms. 524.520 Cuprimyxin cream. 524.1484a Neomycin sulfate ophthalmic oint- 524.575 Cyclosporine ophthalmic ointment. ment. 524.590 Diclofenac. 524.1484b Neomycin sulfate, 524.660 Dimethyl sulfoxide ophthalmic and acetate, tetracaine hydrochloride, and topical dosage forms. myristyl-gamma-picolinium chloride, 524.660a Dimethyl sulfoxide solution. topical powder.

300

VerDate Aug<04>2004 09:52 Apr 28, 2005 Jkt 205070 PO 00000 Frm 00310 Fmt 8010 Sfmt 8010 Y:\SGML\205070.XXX 205070